Remission in Cushing's syndrome with o,p'-DDD.
D015065:17-Hydroxycorticosteroids; D000310:Adrenal Gland Neoplasms / Q000188:drug therapy*; D000311:Adrenal Glands / Q000502:physiology; D000308:Adrenocortical Hyperfunction / Q000188:drug therapy*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000328:Adult; D001769:Blood; D003480:Cushing Syndrome / Q000188:drug therapy*; D003632:Dichlorodiphenyldichloroethane / Q000627:therapeutic use; D005260:Female; D005951:Glucose Tolerance Test; D005965:Glucuronates; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism*; D010912:Pituitary-Adrenal Function Tests; D011485:Protein Binding; D014556:Urine
D015065:17-Hydroxycorticosteroids; D005965:Glucuronates; D000324:Adrenocorticotropic Hormone; D003632:Dichlorodiphenyldichloroethane; D006854:Hydrocortisone